Early stage oxidative stress, inflammatory response, and infection after tendon surgery are highly associated with the subsequent peritendinous adhesion formation, which may diminish the quality and function of the repaired tendon. Although various anti-inflammatory and/or antibacterial grafts have been proposed to turn the scale, most of them suffer from the uncertainty of drug-induced adverse effects, low mechanical strength, and tissue adhesiveness. Here, inspired by the tendon anatomy and pathophysiology of adhesion development, an adhesive and robust dual-layer Janus patch is developed, whose inner layer facing the operated tendon is a multifunctional electrospun hydrogel patch (MEHP), encircled further by a poly-l-lactic acid (PLLA) fibrous outer layer facing the surrounding tissue. Specifically, MEHP is prepared by gelatin methacryloyl (GelMA) and zinc oxide (ZnO) nanoparticles, which are co-electrospun first and then treated by tannic acid (TA). The inner MEHP exhibits superior mechanical performance, adhesion strength, and outstanding antioxidation, anti-inflammation, and antibacterial properties, and it can adhere to the injury site offering a favorable microenvironment for tendon regeneration. Meanwhile, the outer PLLA acts as a physical barrier that prevents extrinsic cells and tissues from invading the defect site, reducing peritendinous adhesion formation. This work presents a proof-of-concept of a drug-free graft with anisotropic adhesive and biological functions to concert the healing phases of injured tendon by alleviating incipient inflammation and oxidative damage but supporting tissue regeneration and reducing tendon adhesion in the later phase of repair and remodeling. It is envisioned that this Janus patch could offer a promising strategy for safe and efficient tendon therapy.
Keyphrases
- anterior cruciate ligament reconstruction
- rotator cuff
- oxidative stress
- anti inflammatory
- drug induced
- stem cells
- inflammatory response
- early stage
- lactic acid
- liver injury
- wound healing
- biofilm formation
- drug delivery
- emergency department
- tissue engineering
- escherichia coli
- squamous cell carcinoma
- minimally invasive
- gene expression
- physical activity
- dna damage
- cystic fibrosis
- pseudomonas aeruginosa
- mesenchymal stem cells
- atrial fibrillation
- staphylococcus aureus
- quantum dots
- bone marrow
- replacement therapy
- coronary artery bypass
- diabetic rats
- endoplasmic reticulum stress
- newly diagnosed
- lipopolysaccharide induced
- living cells
- heat stress
- signaling pathway
- percutaneous coronary intervention
- lps induced
- cell death
- ionic liquid